Persistent microglial activation following neonatal CMV infection mediates neurodegeneration

Jessica L McCord1, Debotri Chatterjee2, John Y S Han3

  • 1Department of Microbiology and Immunology, Jefferson Center for Vaccines and Pandemic Preparedness, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Science Advances
|March 11, 2026
PubMed

Insights

Early-life murine cytomegalovirus (MCMV) infection causes adult-onset neurodegeneration in the brain and retina. Targeting inflammatory microglia with transient depletion preserved neuronal structure and density.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Human cytomegalovirus (HCMV) is a common congenital infection linked to neurological issues.
  • Herpesviruses, including HCMV, are associated with neuroinflammation and neurodegeneration.
  • Neonatal murine cytomegalovirus (MCMV) infection serves as a model for studying congenital viral impacts.

Purpose of the Study:

  • To investigate the long-term neurological consequences of early-life MCMV infection in a murine model.
  • To determine the role of microglia in MCMV-induced adult-onset neurodegeneration.
  • To explore therapeutic potential of modulating microglial activity.

Main Methods:

  • Neonatal mice were infected with MCMV.
  • Adult mice were assessed for neuropathology in the retina and brain.
  • Microglia were transiently depleted using pharmacological agents before pathology onset.
  • Microglial phenotypes and tissue structure were analyzed post-depletion.

Main Results:

  • Early-life MCMV infection led to adult-onset neuron loss and neuropathology in the retina and brain.
  • Persistent, highly activated, inflammatory microglia were associated with pathology.
  • Transient microglia depletion resulted in repopulation by reparative microglia.
  • Microglia depletion alone preserved retinal structure, photoreceptor neurons, and brain neuron density.

Conclusions:

  • Early-life MCMV infection induces pathogenic microglia, driving adult-onset neurodegeneration.
  • Targeting and modulating microglia activity presents a potential therapeutic strategy for congenital viral-induced neurological damage.
  • Microglia play a critical role in the progression and potential resolution of MCMV-associated neuropathology.